Niitaka (4465) Q1 2026 earnings summary

Executive summary

• Revenue/net sales increased 4.8% year-over-year to ¥6,006 million, driven by strong detergent sales and expanded product sales in the Chemical segment.

• Operating income rose 36.6% to ¥582 million, with cost reductions in the Healthcare segment contributing to profit growth.

• Profit attributable to owners of parent surged 41.3% year-over-year to ¥419 million.

• Earnings per share increased to ¥70.99 from ¥50.24 in the prior year period.

• Both Chemical and Healthcare segments achieved higher sales and profits, with the Chemical segment's product sales expansion being a key driver.

Financial highlights

• Gross profit increased 7.2% year-over-year to ¥2,267 million.

• Operating margin improved from 7.4% to 9.7% year-over-year.

• Net income attributable to shareholders rose 41.3% to ¥419 million.

• Comprehensive income rose to ¥479 million from ¥364 million year-over-year.

• Net assets grew to ¥14,929 million, with an equity ratio of 65.0%.

Segment performance

• Chemical segment revenue grew 4.7% to ¥5,642 million, with operating profit up 34.6% to ¥468 million; margin improved to 8.3%.

• Healthcare segment revenue increased 5.9% to ¥363 million, with operating profit up 45.8% to ¥113 million; margin rose to 31.3%.

• Chemical segment benefited from robust detergent demand in the foodservice market and adoption by major chains.

• Healthcare segment saw overseas sales growth and cost reductions, offsetting domestic declines.